Covid vaccination guidance – April 2021
New guidance issued over the last month largely relates to changes in advice around the use of the AstraZeneca vaccine, and licensing of the Moderna vaccine.
AstraZeneca
Lots of guidance relating to the AstraZeneca vaccine has been issued or updated in April, following concerns about the risk of blood clots and subsequent MHRA advice on this risk.
- Patient information leaflet, updated 15 April 2021.
- Healthcare professional information leaflet, updated 15 April 2021.
- Conditions of Authorisation, updated 15 April 2021.
- Summary of the Public Assessment Report, updated 15 April 2021.
- Information for healthcare professionals on blood clotting following Covid-19 vaccination, updated 9 April 2021.
- MHRA confirms that people should continue to receive the Covid-19 vaccine AstraZeneca, updated 7 April 2021.
- MHRA issues new advice, concluding a possible link between Covid-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, published 7 April.
Moderna
The Moderna vaccine has now been approved for use and is currently being provided at three sites in London. If and when it is made widely available to GP run sites, we will provide further updates.
- Patient information leaflet, updated 19 April 2021.
- Patient Group Direction, updated 19 April 2021.
- Regulatory approval documents, updated 19 April 2021.
- National protocol, updated 8 April 2021.
- Letter from the JCVI on use of the Moderna vaccine in the Covid-19 immunisation programme, published 7 April 2021.
Dr Michelle Drage's statement on the new Secretary of State for Health and Social Care (10 Jul 2018)
Dr Michelle Drage responds to the appointment of Matthew Hancock as Secretary of State for Health and Social Care. "Congratulations and welcome to new Health Secretary Matthew Hancock. "I’d love...Perinatal mental health access variation (06 Jul 2018)
The Pan-London Perinatal Mental Health Network are gathering information on disparities in access to, and funding for, perinatal mental health within secondary and tertiary care. This map produced by the...Salisbury Novichok 1 incident - Public Health England interim guidance (05 Jul 2018)
Following the recent Salisbury Novichok 1 incident, Public Health England have issued interim guidance on the diagnosis and early management in organophosphate chemical incidents. This guidance can be downloadedLondonwide LMCs' June 2018 newsletter (20 Jun 2018)
...Tips of the month June 2018 (20 Jun 2018)
We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...Free online mindfulness course for patients (19 Jun 2018)
Londoners can now access a free online mindfulness tool via the Good Thinking website. The website signposts individuals to resources to help deal with depression, anxiety, stress and insomnia...GP State of Emergency continues (19 Jun 2018)
Since April 2016 when GPs in London and across the country declared a GP State of Emergency, our campaign has been a great success. However, we recognise that the...SNOMED CT update for SystmOne practices (19 Jun 2018)
The first phase of the national deployment of SNOMED CT has now taken place with approximately 20 pilot sites taking part. The wider roll-out for SystmOne GP practices will be...Publication of Integrated Care - Organisations, Partnerships and Systems (19 Jun 2018)
Online report PDF download The Committee considered the increasing reliance on a range of health and care services, which are mostly...KO41b returns not mandatory for 2018 (19 Jun 2018)
The window for practices to complete and submit the 2017/18 NHS complaints data return closed on Friday 8 June. The BMA has previously advised that practices are under no legal...Guidance
We provide expert guidance for practices in our guidance section, as well as an archive of other materials you may find useful.
GP Support
Contact our GP Support team if you need help or advice.
The team provide professional and pastoral support to GPs and practice teams on a broad range of issues.